Glenmark Pharma gains 15% on launch of Favipiravir, a potential Covid drug

The company launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet.

from Home Page https://ift.tt/2zVp6w4